Molecular targets in gastric cancer and apoptosis

Apoptosis in Carcinogenesis and Chemotherapy: Apoptosis in Cancer

Volumn 9781402095979, Issue , 2009, Pages 157-192

  Balcer Kubiczek, Elizabeth K ^a   Garofalo, Michael C ^a  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

Apoptosis; Cancer regulators; Gastric cancer; microRNA; Stem cells

Indexed keywords

EID: 84919652829     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-9597-9_7     Document Type: Chapter

References (205)

1. Aarnio M, Salovaara R, Aaltonen LA, Mecklin JP, Jarvinen HJ (1997) Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 74:551-555
2. Ajani JA, Mayer R, Ota DM, Steele GD, Evans D, Roh M, Sugarbaker DJ, Dumas P, Gray C, Vena DA, Stablein DM (1993) Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma. J Natl Cancer Inst 85:1839-1844
3. Akao Y, Nakagawa Y, Naoe T (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29:903-906
4. Al-Haji M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:393-3938
5. Altieri DC (2008) Survivin, cancer networks and pathway-directed drug discovery. Nature Rev Cancer 8:61-70
6. Ashkenazi A, Dixit VM (1998) Death receptors, signaling and modulation. Science 281:305-1308
7. Bahmanyar S, Ye W, Dickman PW, Nyren O (2007) Long-term risk of gastric cancer by subsite in operated and unoperated patients hospitalized for peptic ulcer. Am J Gastroenterol 102:1185-1191
8. Baigude H, McCarroll J, Yang CS, Swain PM, Rana TM (2007) Design and creation of new nanomaterials for therapeutic RNAi. ACS Chem Biol 2:237-241
9. Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimmer dissociation. Nature 421:499-506
10. Balcer-Kubiczek EK, Harrison GH, Xu JF, Gutierrez PL (2002) Coordinate late expression of trefoil peptide genes (pS2/TFF1 and ITF/TFF3) in human breast, colon, and gastric tumor cells exposed to X-rays. Mol Cancer Ther 1:405-415
11. Balcer-Kubiczek EK, Attarpour M, Jiang J, Kennedy AS, Suntharalingam M (2006) Cytotoxicity of docetaxel (Taxotere®) used as a single agent and in combination with radiation in human gastric, cervical and pancreatic cancer cells. Chemotherapy 52:231-240
12. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760
13. Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type 53 activity. EMBO J 12:461-468
14. Bauer UM, Daujat S, Nielsen SJ, Nightingale K, Kouzarides T (2002) Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO 3:39-44
15. Berezikov E, van Tetering G, Verheul M, van de Belt J, van Laake L, Vos J, Verloop R, van de Wetering M, Guryev V, Takada S, van Zonneveld AJ, Mano H, Plasterk R, Cuppen E (2006) Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res 16:1289-1298
16. Bird AP, Wolffe AP (1999) Methylation-induced repression - belts, braces and chromatin. Cell 99:451-454
17. Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, Liu CG, Schmittgen TD, Reinhold WC, Croce CM, Weinstein JN, Sadee W (2008) MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7:1-9
18. Bockbrader KM, Tan M, Sun Y (2005) A small molecule Smac mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Oncogene 24:7381-7388.
19. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoiec cell. Nat Med 3:730-737
20. Bossenmeyer-Pourié C, Kannan R, Ribieras S, Wendling C, Stoll I, Thim L, Tomasetto C, Rio MC (2002) The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol 157:761-770
21. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 230:170-178
22. Bravo LE, van Doorn LJ, Realpe JL, Correa P (2002) Virulence-associated genotypes of Helicobacter pylori: Do they explain the African enigma? Am J Gastroenterol 97:2839-2842
23. CALGB 80101: Phase III Randomized Study of Adjuvant Chemoradiation After Resection in Patients with Gastric or Gastroesophageal Adenocarcinoma. Accessed at http://www.cancer.gov/clinicaltrials/CALGB-80101 on April 6, 2008
24. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM (2002) Frequent deletion and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524-15529
25. Calin GA, Croce CM (2006) MicroRNA signatures in human cancer. Nature Rev Cancer 6:857-866
26. Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M (2006) CpG islands methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res 12:2995-3002
27. Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC (2005) RUNX3 suppresses gastric epithelial cell growth by inducing p21 (WAF1/Cip1) expression in cooperation with transforming growth factor β-activated SMAD. Mol Cell Biol 25:8097-8107
28. Cleary ML, Sklar J (1985) Nucleotide sequence of a t (14;18) chromosomal breakpoint in a follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439-7443
29. Cohen MM (2003) Molecular dimensions of gastrointestinal tumors: Some thoughts for digestion. Am J Med Genetics 122 A: 303-314
30. Correa P, Schneider BG (2005) Etiology of gastric cancer: What is new? Cancer Epidemiol Biomarkers Prev 14:1865-1869
31. Cui G, Takaishi S, Ai W, Betz KS, Florholmen J, Koh TJ, Houghton J, Pritchard DM, Wang TC (2006) Gastrin-induced apoptosis contributes to carcinogenesis in the stomach. Lab Invest 86:1037-1051
32. Cullinan SA, Moertel CG, Fleming TR, Rubin JR, Krook JE, Everson LK, Windschitl HE, Twito DI, Marschke RF, Foley JF, et al. (1985) A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma: Fluorouracil versus fluorouracil and doxorubicin versus fluorouracil, doxorubicin and mitomycin. JAMA 253:2061-2067
33. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20
34. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522-1530
35. Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer. Nature 25:6170-6175
36. de Maat M F G, van de Velde C J H, Umetani N, de Heer P, Putter H, van Hoesel AQ, Meijer GA, van Grieken NC, Kuppen PJ, Bilchik AJ, Tollenaar RA, Hoon DS (2007) Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in cancer patients. J Clin Oncol 25:4887-4894
37. Deeks ED, Scott LJ (2007) Docetaxel in gastric cancer. Drugs 67:1893-1901
38. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407-1427
39. Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457-463
40. Elmén J, Lindow M, Schütz, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452:896-899
41. El-Omar EM, Chow WH, Rabkin CS (2001) Gastric Cancer and H. pylori: Host genetics open the way. Gastroenterology 121:1002-1013
42. Espey DK, Wu XC, Swan J Wiggins C, Jim MA, Ward E, Wingo PA, Howe HL, Ries LA, Miller BA, Jemal A, Ahmed F, Cobb N, Kaur JS, Edwards BK (2007) Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in Indian Americans and Alaska Natives. Cancer 110:2119-2152
43. Esquela-Kerscher A, Stack FJ (2006) Oncomirs - microRNA with a role in cancer. Nature Rev Cancer 6:259-269
44. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S (2004) Increased methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple islands in gastric cancer. Am J Pathol 164:689-699
45. Fenaux P (2005) Inhibitors of DNA methylation: beyond myelodysplastic syndromes. Nat Clin Pract Oncol Suppl 1:S36-S44
46. Fesik SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev 5:876-885
47. Fisher U, Schultze-Osthoff K (2005) Apoptosis-based therapies and drug targets. Cell Death Differ 12:942-961
48. Fulda S (2008) Modulation of TRAIL-induced apoptosis by HDAC inhibitors. Curr Cancer Drug Targets 8:132-140
49. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011-7021
50. Gaymes TJ, Padua RA, Pla M, Orr S, Omidvar N, Chomienne C, Mufti GJ, Rassool FV (2006) Histone deaceltylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis? Mol Cancer Res 4:563-573
51. Genta Inc (2007) Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G3139, GC3139, oblimersen sodium. Drugs RD 8:321-334
52. Giles RH, van Es JH, Clevers H (2003) Caught up in a Wnt storm: Wnt signaling in cancer, Biochim Biophys Acta 1653:1-24
53. Giraud AS, Jackson C, Menheniott TR, Judd LM (2007) Differentiation of the gastric mucosa. IV. Role of trefoil peptides and IL-6 cytokine family signaling in gastric homeostasis. Am J Physiol Gastrointest Liver Physiol 292:G1-G5
54. Glimelius B, Hoffmann K, Haglund U, Nyrén O, Sjödén PO (1994) Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol 5:189-190
55. Goldberg AD, Allis CD, Bernstein E (2007) Epigenetics: A landscape takes shape. Cell 128:635-638
56. Gonzàlez CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, Ferrari P, Boeing H, del Giudice G, Plebani M, Carneiro F, Nesi G, Berrino F, Sacerdote C, Tumino R, Panico S, Berglund G, Simán H, Nyrén O, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Day NE, Linseisen J, Nagel G, Bergmann MM, Overvad K, Jensen MK, Tjonneland A, Olsen A, Bueno-de-Mesquita HB, Ocke M, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Trichopoulou A, Psaltopoulou T, Roukos D, Lund E, Hemon B, Kaaks R, Norat T, Riboli E (2006) Meat intake and risk of stomach and esophageal adenocarcinomas within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98:345-354
57. Grinstein E, Wernet P (2007) Cellular signaling in normal and cancerous stem cells. Cell Signal 19:2428-2433
58. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402-405
59. Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic look): clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Biol Phys 8:1-11
60. Hall EJ, Wuu CS (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56:83-88
61. Hanahan D, Weinberg RA (2000) The hallmark of cancer. Cell 100:57-70
62. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, Mori M (2006) Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24:506-513
63. Harris RG, Herzog EL, Brusia EM, Grove JE, Van Arnam JS, Krause DS (2004) Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 305:90-93
64. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069-2077
65. Hatfield S, Ruohola-Baker H (2008) microRNA and stem cell function. Cell Tissue Res 331:5766
66. Haupt Y, Barak Y, Oren M (1996) Cell-specific inhibition of p53-mediated apoptosis by mdm1. EMBO J 15:1596-1606
67. Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12:20-37
68. He X, He L, Hannon GJ (2007) The guardian's little helper: MicroRNA in the p53 tumor suppressor pathway. Cancer Res 67:11099-11101
69. Henderson C, Mizzau M, Paroni G (2003) Role of caspases, Bid and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem 278:12579-12568
70. Holcombe C (1990) Helicobacter pylori: The African enigma. Gut 33:429-431
71. Hong S, Lee C, Kim SJ (2007) Smad7 sensitizes tumor necrosis-factor through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-κB pathway. Cancer Res 67:9577-9583
72. Houghton JM, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568-1571
73. Huang C, Ida H, Ito K, Zhang H, Ito Y (2007) Contribution of reactivated RUNX3 to inhibition of gastric cancer growth following suberoylanilide hydroxamic acid (vorinostat) treatment. Biochem Pharmacol 73:990-1000
74. Hull MA (2005) Cycloxygenase-2: How good is it as a target for chemoprevention? Eur J Cancer 41:1854-1863
75. Hutvágner G, Simard MJ, Mello CC, Zamore PD (2004) Sequence-specific inhibition of small RNA function. PloS Biol 2:E98.
76. IARC (2000) Tumors of the Digestive Tract. International Agency for Research on Cancer, IARC Press, Lyon
77. Inada T, Kikuyama S, Ichikawa A, Igarashi S, Ogata (1998) Bcl-2 expression as a prognostic factor of survival of gastric carcinoma. Anticancer Res 18:2003-2010
78. Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M (2000) Mutational inactivation of the proapoptotic gene BAX confers selective advantage during clonal evolution. Proc Natl Acad Sci USA 97:10872-10877
79. Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y (2005) RUNX3, a novel tumor suppressor gene, is frequently inactivated in gastric cells by protein mislocalization. Cancer Res 65:7743-7750
80. Ito Y (2004) Oncogenic potential of the RUNX gene family: "Overview". Oncogene 23:4198-4208
81. Ito Y (2008) RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res 99:33-76
82. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66
83. Japanese Research Society for Gastric Cancer (1993) The General Rules for Gastric Cancer Study in Surgery and Pathology, 12th ed. Kanahara Shuppan, Tokyo
84. John M, Constien R, Akinc A, Goldberg M, Moon YA, Spranger M, Hadwiger P, Soutschek J, Vornlocher HP, Manoharan M, Stoffel M, Langer R, Anderson DG, Horton JD, Koteliansky V, Bumcrot D (2007) Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 449:745-747
85. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ (2005) RAS is regulated by the let-7 family. Cell 120:635-647
86. Jung EM, Park JW, Choi KS, Park JW, Lee HI, Lee KS, Kwon TK (2006) Curcumin sensitizes tumor necrotic factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis 27:2008-2017
87. Jung IM, Chung JK, Kim YA, Kim JE, Heo SC, Ahn YJ, Hwang KT, Kim BG, Lee KL, Kim CW, Kim WH, Chang MS (2007) Epstein-Barr virus, beta-catenin, and E-cadherin in gastric cancer. J Korean Med Sci 22:855-611
88. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY (2002) Epstein-Barr viruspositive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160:787-794
89. Kelly WK, Richon VM, O'Connor O, Curley T, MacGregor-Curtelli B, Tong W, Klang M, Schwartz L, Richardson S, Rosa E, Drobnjak M, Cordon-Cordo C, Chiao JH, Rifkind R, Marks PA, Scher H (2003) Phase I clinical trial of histone inhibitor Suberoylamilide hydroxamic acid administered intravenously. Clin Cancer Res 9:3578-3588
90. Kerr J F R, Wyllie AH, Currie AR (1972) Apoptosis: A basic biological phenomenon with wideranging implications in tissue kinetics. Br J Cancer 26:239-257
91. Khan ZE, Wang TC, Cui G, Chi AL, Dimaline R (2003) Transcriptional regulation of the human trefoil factor, TTF1, by gastrin. Gastroenterology 125:510-521.
92. Kim CJ, Cho YG, Park CH, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS (2004a) Genetic alterations of the MYH gene in gastric cancer. Oncogene 23:6820-6822.
93. Kim DN, Chae HS, Oh ST, Kang JH, Park CH, Park WS, Takada K, Lee JM, Lee WK, Lee SK (2007) Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81:1033-1036
94. Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS (2008) Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/Enhancerbinding protein homologous protein-dependent DR5 up-regulation. Cancer Res 68:266-275
95. Kim H, Kim EH, Eom YW, Kim WH, Kwon TK, Lee SJ, Choi KS (2006) Sulforaphane sensitizes tumor necrotic factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive species-mediated up-regulation of DR5. Cancer Res 66:1740-1750
96. Kim JM, Sohn HY, Yoon SY, Oh JH, Yang JO, Kim JH, Song KS, Rho SM, Yoo HS, Kim YS, Kim JG, Kim NS (2005a) Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 11:473-482
97. Kim MA, Lee HS, Yang HK, Kim WH (2005b) Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer 103:1439-1446
98. Kim YH, Lee HS, Lee HJ, Hur K, Kim WH, Bang YJ, Kim SJ, Lee KU, Choe KJ, Yang HK (2004b) Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinoma. Ann Oncol 15:574-580
99. Kitayama Y, Igarashi H, Sugimura H (2000) Different vulnerability among chromosomes to numerical instability in gastric carcinogenesis: Stage-dependent analysis by FISH with the use of microwave irradiation. Clin Cancer Res 6:3139-3146
100. Kondo Y, Shen L, Issa JP (2003) Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 23:206-213
101. Konturek PC, Pierzchalski P, Konturek SJ, Meixner H, Faller G, Kirchner T, Hahn EG (1999) Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. Scand J Gastroenterol 34:375-383
102. Konturek PC, Konturek SJ, Sulekova Z, Meixner H, Bielanski W, Starzynska T, Karczewska E, Marlicz K, Stachura J, Hahn EG (2001) Expression of hepatocyte growth factor, transforming factor alpha, apoptosis-related Bax and Bcl-2 and gastrin in human gastric cancer. Aliment Pharmacol Ther 15:989-999
103. Koriyama C, Akiba S, Itoh T, Sueyoshi K, Minakami Y, Corvalan A, Yonezawa S, Eizuru Y (2007) E-cadherin and beta catenin expression in Epstein-Barr virus-associated gastric carcinoma and their prognostic significance. World J Gastroenterol 13:3925-3931
104. Koscianska E, Baev V, Skreka K, Oikonomaki K, Rusinov V, Tabler M, Kalantidis K (2007) Prediction and preliminary validation of oncogene regulation by miRNAs. BMC Mol Biol 8:1-14
105. Kouraklis G, Theocharis S (2006) Histone deacetylase inhibitors: a novel target of anticancer therapy (review). Oncol Reports 15:489-494
106. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M (2005) Silencing microRNAs in vivo with "antagomirs". Nature 438:685-689
107. Kume T, Oshima K, Shinohara T, Takeo H, Yamashita Y, Shirakusa T, Kikuchi M (1999) Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus-associated gastric carcinoma. Histopathology 34:502-509
108. Lauren P (1965) The two histological main types of gastric carcinoma diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 64:31-49.
109. Lauwers GY, Scott GV, Karpeh MS (1995) Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinoma. Cancer 75:2209-2213
110. Lee HS, Chang MS, Yang HK, Lee BL, Kim WH (2004) Epstein-Barr virus positive-gastric carcinomas a distinct protein expression profile in comparison with Epstein-Barr virus negativegastric carcinoma. Clin Cancer Res 10:1698-1705
111. Lee JY, Eom EM, Kim DS, Ha-Lee YM, Lee DH (2003) Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. Genomics 82:78-85
112. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM (2007) Identification of pancreatic stem cells. Cancer Res 67:1030-1037
113. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC (1998) Control of apoptosis and mitotic checkpoint by surviving. Nature 396:580-584
114. Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG (2004) A small molecule Smac mimic potentates TRAIL- and TNFα-mediated cell death. Science 305:1471-1474
115. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y (2002) Causal relationship between the loss of RUNX3 expression and gastric carcinogenesis. Cell 109:113-124
116. Li Z, Zhan W, Wang Z, Zhu B, He Y, Peng J, Cai S, Ma J (2006) Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun 348:229-237
117. Lindor NM, Greene MH (1998) The concise handbook of family cancer syndromes. Mayo familial cancer program. J Natl Cancer Inst 90:1039-1071
118. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67
119. Loeb LA (1994) Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54:5059-5063
120. Lowery AJ, Miller N, McNeill RE, Kerin MJ (2008) MicroRNAs as indicators and therapeutic targets: Potential effect on breast management. Clin Cancer Res 14:360-365
121. Lynch HT, Grady W, Suriano G, Huntsman D (2005) Gastric cancer: New genetic developments. J Surg Oncol (Seminars) 90:114-133
122. Machado JC, Carneiro F, Blin N, Sobrinho-Simões M (1996) Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa. Eur J Cancer Prev 5:169-179
123. MacDonald JS, Schein PS, Woolley PV, Smythe T, Ueno W, Hoth D, Smith F, Boiron M, Gisselbrecht C, Brunet R, Lagarde C (1980) 5-Fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 93:533-536
124. MacDonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730
125. Marks PA, Richon VM, Miller T, Kelly WK (2004) Histone deacetylase inhibitors. Adv Cancer Res 91:137-168
126. Meng CF, Zhu XJ, Peng G, Dai DQ (2007) Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. World J Gastroentorol 13:6166-6171
127. Meng H, Lu CD, Sun YL, Dai DJ, Lee SW, Tanigawa N (2004) Expression of level of wildtype survivin in gastric cancer is an independent predictor of survival. World J Gastroenterol 10:3245-3250
128. Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W (2005) Histone H3 acetylation is associated with reduced p21WAF1/CIP1 expression by gastric carcinoma. J Pathol 205:65-73.
129. Moertel C, Childs D, Reitemeier R, Colby MY Jr, Holbrook MA (1969) Combined 5-fluorouracil and supervoltage radiation therapy for locally unresectable gastrointestinal cancer. Lancet 2:865-867
130. Moggs JG, Goodman JI, Trosko JE, Roberts RA (2004) Epigenetics and cancer: implications for drug discovery and safety assessment. Toxicol Appl Pharmacol 196:422-430
131. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M (1993) Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 72:37-41
132. Nam KT, Hahm KB, Oh SY, Yeo M, Han SU, Ahn B, Kim YB, Kang JS, Jang DD, Yang KH, Kim DY (2004) The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin Cancer Res 10:8105-8113
133. O'Brien S, Moore JO, Boyd TE, Larratt LM, Skotnicki A, Koziner B, Chanan-Khan AA, Seymour JF, Bociek RG, Pavletic S, Rai KR (2007) Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium in patients with relapsed of refractory chronic lymphocytic leukemia. J Clin Oncol 25:1114-1120
134. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc related microRNAs modulate E2F1 expression. Nature 435:839-843
135. Oh JH, Yang JO, Hahn Y, Kim MR, Byun SS, Jeon YJ, Kim JM, Song KS, Noh SM, Kim S, Yoo HS, Kim YS, Kim NS (2005) Transcription analysis of human gastric cancer. Mammalian Genome 16:942-954
136. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25:1696-1708
137. Pardal R, Clarke MF, Morrison SJ (2003) Applying the principles of stem-cell biology to cancer. Nat Rev 3:895-902
138. Park JG, Yang HK, Kim WH, Caldas C, Yokota J, Guilford PJ (2000a) Report on the first meeting of the International Collaborative Group on Hereditary Gastric Cancer. J Natl Cancer Inst 92:1781-1782
139. Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NJ, Lee JY (2000b) Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119:691-698
140. Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NJ, Lee JY (2000c) Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119:891-898
141. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533-553
142. Peart MJ, Smyth GK, van Laar RK, Bowtell DD, Richon VM, Marks PA, Holloway AJ, Johnstone RW (2005) Identification and functional significance of genes regulated by structurally different histone inhibitors. Proc Natl Acad Sci USA 102:3697-3702
143. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM, Vecchione A (2008) E2F1-regulated microRNA impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13:272-286
144. Philips TM, McBride WH, Pajonk F (2006) The response of CD24 (-/low)/CD44+ breast cancerinitiating cells to radiation. J Natl Cancer Inst 98:1755-1757
145. Piccirillo S G M, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL (2006) Bone morphogenic proteins inhibit the tumorigenic potential of human brain tumor-initiating cells. Nature 444:761-765
146. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105:1608-1613.
147. Potten CS (1992) The significance of spontaneous and induced apoptosis in the gastrointestinal tract in mice. Cancer Metastasis Rev 11:179-195
148. Powell J, McConkey CC (1992) The rising trend in oesophageal adenocarcinomas and gastric cardia. Eur J Cancer Prev 1:265-269
149. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K (2007) Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168:1-64
150. Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M (1995) Randomized comparison of fluorouracil, epirubicin and methotrexate (FEMTX) plus supportive care versus supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587-591
151. Qiao XT, Ziel JW, McKimpson W, Madison BB, Todisco A, Merchant JL, Samuelson LC, Gumucio DL (2007) Prospective identification of a multilineage progenitor in murine stomach epithelium Gastroenterology 133:1989-1998
152. Reed JC (2006) Drug insight: cancer therapy strategy based on restoration of endogenous cell death mechanisms. Nat Clin Practice 3:388-398
153. Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J (1990) Anti-sensemediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparison of phosphodiester and phosphorothioate digoxynucleotide. Cancer Res 50:6565-6570.
154. Reya T, Morrison SJ, Clarke MF (2001) Stem cells, cancer and cancer stem cells. Nature 414:105-111
155. Ribieras S, Lefèbvre O, Tomassetto C, Rio C (2001) Mouse Trefoil Factor genes: genomic organization, sequences, and methylation analysis. Gene 266:67-75
156. Ribieras S, Tomasetto C, Rio MC (1998) The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim Biophys Acta 1378:F61-F77
157. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2007) Identification and expansion of human-colon-cancer-initiating cells. Nature 445:111-115
158. Richon VM, Sandhoff TW, Rifkind RA, Marks PA (2000) Histone deacetylase inhibitor selectively induces p21/WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 97:10014-10019
159. Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH, Wong MH (2006) Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA 103:6321-6325
160. Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR (1998) Classification of regional lymph node metastases from gastric carcinoma. German Gastric Cancer Study Group. Cancer 82:621-631
161. Roder DM (2002) The epidemiology of gastric cancer. Gastric Cancer 5:5-11
162. Ruefli AA, Ausserlechner MJ, Bernhard D, Sutton VR, Tainton KM, Kofler R, Smyth MJ, Johnstone RW (2003) The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc Natl Acad Sci USA 98:10833-10838
163. Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A (2002) Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20:1996-2004
164. Sassen S, Miska EA, Caldas C (2008) MicroRNA-implications for cancer. Virchows Arch 452:1-10
165. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008) MicroRNA expression profiles associated with prognosis and therapeutic out in colon adenocarcinoma. JAMA 299:425-436
166. Segal I, Ally R, Mtchell H (2001) Helicobacter pylori - an African perspective. Q J Med 94:561-565
167. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy death receptors. Science 277:818-821
168. Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T (2005) Tunicamycin enhances tumor necrotic factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res 65:6364-6370
169. Siavoshi F, Malekzadeh S, Daneshmand M, Ashktorab H (2005) Helicobacter pylori and gastric disease. Dig Dis Sci 50:2075-2080
170. Sidoni A, Lancia D, Pietropauli N, Ferri I (1989) Changing patterns in gastric carcinoma. Tumori 75:605-608.
171. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432:396-401
172. Smalley SR, Gunderson L, Tepper JE, Martenson JA, Minsky B, Willett C, Rich T (2002) Gastric surgical adjuvant radiotherapy consensus report - rationale and treatment implementation. Int J Radiat Oncol Biol Phys 52:283-293
173. Smith MG, Hold GL, Tahara E, El-Omar EM (2006) Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12:2979-2990
174. Song SH, Jong HS, Choi HH, Inoue H, Tanabe T, Kim NK, Bang YJ (2001) Transcriptional silencing of Cyclooxygenase-2 by hypermethylation of the 5'CpG island in human gastric carcinoma cells. Cancer Res 61:4628-4635
175. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci USA 103:2746-2751
176. Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S (2008) The utility of LNA in micro-RNA-based cancer diagnostics and therapeutics. Semin Cancer Biol 18:89-102
177. Suit H, Goldberg S, Niemierko A, Ancukiewicz M, Hall E, Goitein M, Wong W, Paganetti H (2007) Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodents subjects. Radiat Res 167:12-42
178. Suzuki K, Ohnami S, Tanabe C, Sasaki H, Yasuda J, Katai H, Yoshimura K, Terada M, Perucho M, Yoshida T (2003) The genomic damage estimated by arbitrary primed PCR DNA fingerprinting is useful for prognosis of gastric cancer. Gastroenterology 125:1330-1340
179. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 103:11154-11159
180. Tahara E (2004) Genetic pathways of two types of gastric cancer. IARC Sci Publ 157:327-349
181. Tahara E, Semba S, Tahara H (1996) Molecular biological observations in gastric cancer. Semin Oncol 23:307-315
182. Takada K (2000) Epstein-Barr virus and gastric carcinoma. Mol Path 53:255-264
183. Takakura M, Kyo S, Sowa Y, Wang Z, Yatabe N, Maida Y, Tanaka M, Inoue M (2001) Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res 29:3006-3011
184. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T (2004) Reduced expression of the let-7 microRNA in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753-3756
185. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, Issa JP (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59:5438-5442
186. Ungerstedt JS, Sowa Y, Xu WS, Shao Y, Dokmanovic M, Perez G, Ngo L, Holmgren A, Jiang X, Marks PA (2005) Role of thioredoxin in response of normal and transformed cells to histone deacetylase inhibitors. Proc Natl Acad Sci USA 102:673-678
187. Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, Rani BR, Sakuma K, Nagai H, Fukayama M (2007) p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 120:60-66
188. Varley JM (2003) Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mut 21:313-320
189. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA; V325 Study Group (2006) Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as firstline therapy for advanced gastric cancer: A report of the V325 Study Group. J Clin Oncol 24:4991-4997
190. Vasudenvan S, Tong Y, Steitz JA (2007) Switching from repression to activation: MicroRNAs can up-regulate translation. Science 318:1931-1934
191. Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W (2003) Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 39:1603-1609
192. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261
193. Wabinga H (2005) Helicobacter pylori and histopathological changes of gastric mucosa in Uganda population with varying prevalence of stomach cancer. Afr Health Sci 5:234-237
194. Wacheck V, Heere-Ress E, Halaschek-Wiener J, Lucas T, Meyer H, Eichler HG, Jansen B (2001) Bcl-2 antisense oligonucleotide chemosensitize human gastric cancer in a SCID mouse xenotransplantation model. J Mol Med 79:587-593
195. Waldman T, Lengauer C, Kinzler KW, Vogelstein B (1996) Uncoupling of S phase and mitosis induced by anticancer drugs in cells lacking p21. Nature 381:713-716.
196. Weichert W, Roške A, Gekeler V, Beckers T, Ebert MP, Pross M, Dietel M, Denkert C, Röcken C (2008) Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol 9:139-148
197. Wieland C, Hymmen U (1970) Megavoltage therapy for malignant gastric tumors. Strahlenther Onkol 140:20-26
198. Xing CZ, Kato S, Matsukura N, Matsuda N, Xu H, Takashi E, Yamada N, Naito Z, Tajiri T (2005) Interleukin-8, cyclo-oxygenase-2, and trefoil factor family 1 gene expression and their association with Helicobacter pylori infection in the remnant stomach. Surg Today 35:1026-1032
199. Yang M, Guo Y, Zhang X, Miao X, Tan W, Sun T, Zhao D, Yu D, Liu J, Lin D (2007) Interaction of p53 Arg72Pro and MDM2 T309G polymorphisms and their association with risk of gastric cardia cancer. Oncogene 28:1996-2001
200. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ (2008) MicroRNA expression profiling in human ovarian cancer: miRNA-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68:425-433
201. Yio X, Diamond M, Zhang JY, Weinstein H, Wang LH, Werther L, Itzkowitz S (2006) Trefoil factor family 1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 130:1696-1706
202. Yoo NJ, Kim HS, Kim SY, Park WS, Kim SH, Lee JY, Lee SH (2002) Stomach cancer highly expresses both initiator and effector caspases; an immunohistochemical study. APMIS 110:825-832
203. Yoo NJ, Lee JW, Kim YJ, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, Lee SH (2004) Loss of caspase-2, -6, and -7 expression in gastric cancer. APMIS 112:330-335
204. Yu F, Yao H, Zhu P, et al. (2007) let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell 131:1109-1123
205. Zhang HH, Wang XJ, Li GX, Yang E, Yang NM (2007) Detection of let-7a microRNA by real time PCR in gastric carcinoma. World J Gastroenterol 13:2883-2888